Furthermore, our copy number variation analysis of primary human endometrial cancers demonstrates that CTCF deletion occurs more commonly in tumours with a propensity for relapse or metastasis, and in tumours with clear cell histology. The gene discussed is CTCF; the disease is neoplasm.